학술논문
'학술논문'
에서 검색결과 117건 | 목록
1~10
Academic Journal
Report
University of Cambridge; University College, London; Imperial College London; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; University of Southampton; National Institute for Health Research, United Kingdom
Vickers D, Salorio-Corbetto M, Driver S, Rocca C, Levtov Y, Sum K, Parmar B, Dritsakis G, Albanell Flores J, Jiang D, Mahon M, Early F, Van Zalk N, Picinali L. Involving Children and Teenagers With Bilateral Cochlear Implants in the Design of the BEARS (Both EARS) Virtual Reality Training Suite Improves Personalization. Front Digit Health. 2021 Nov 12;3:759723. doi: 10.3389/fdgth.2021.759723. eCollection 2021.
Salorio-Corbetto M, Williges B, Lamping W, Picinali L, Vickers D. Evaluating Spatial Hearing Using a Dual-Task Approach in a Virtual-Acoustics Environment. Front Neurosci. 2022 Mar 8;16:787153. doi: 10.3389/fnins.2022.787153. eCollection 2022.
A Randomised Controlled Trial to Evaluate the Effectiveness of Spatial-listening Training Delivered Via the Both EARS Training Package (BEARS) in Older Children and Teenagers With Bilateral Cochlear Implants
Salorio-Corbetto M, Williges B, Lamping W, Picinali L, Vickers D. Evaluating Spatial Hearing Using a Dual-Task Approach in a Virtual-Acoustics Environment. Front Neurosci. 2022 Mar 8;16:787153. doi: 10.3389/fnins.2022.787153. eCollection 2022.
A Randomised Controlled Trial to Evaluate the Effectiveness of Spatial-listening Training Delivered Via the Both EARS Training Package (BEARS) in Older Children and Teenagers With Bilateral Cochlear Implants
Report
Validation of UK Protocols to Exclude Brain Blood Flow During Normothermic Regional Perfusion (NRP)
Report
Universitaire Ziekenhuizen KU Leuven; Radboud University Medical Center; The Netherlands Cancer Institute; University Hospital, Basel, Switzerland; University of Zurich; University Medical Center Groningen; Isala; Tianjin Medical University Cancer Institute and Hospital; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Cardiff University; The Leeds Teaching Hospitals NHS Trust; The Christie NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Hospital Israelita Albert Einstein; University of Pennsylvania; Liverpool Hospital, South Western Sydney Local Health District; MVR Cancer Centre and Research Institute India; H. Lee Moffitt Cancer Center and Research Institute; Oslo University Hospital; Christian Medical College, Vellore, India; Fudan University; Swiss Institute of Bioinformatics; Guangdong Provincial People's Hospital; National Institute of Technology Calicut; Maastricht University
ARtificial Intelligence for Gross Tumour vOlume Segmentation
Report
European Institute for Biomedical Imaging Research (EIBIR), Austria; University Hospital, Aachen; Vall d'Hebron Institute of Oncology; Mitera Hospital; Radboud University Medical Center; UMC Utrecht; Ribera Salud Hospitals, Spain; Fraunhofer Institute for Digital Medicine (MEVIS), Germany; University Hospital, Zürich; Cambridge University Hospitals NHS Foundation Trust
Saldanha OL, MutHS, Grabsch H Langer R, Dlh B, Kohlruss M, Keller G, van Treeck M, Hewt KJ, Kolbger FR, Veldhuen GP, Boor P, Foersch S, Truhn D, Kather JN. Dect predtn of genet aberratns from pathology ages gastr cancer wh swarm learng. Gastr Cancer. 2023 Mar;26(2):264-274. do 10.1007/s10120-022-01347-0. Epub 2022 Oct 20.
A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence
A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence
Report
Adler AF, Cardoso T, Nolbrant S, Mattsson B, Hoban DB, Jarl U, Wahlestedt JN, Grealh S, Bjorklund A, Parmar M. hESC-Dered Dopamerg Transplants tegrate to Basal Gangl Ccury a Preclal Model of Parkson's Dease. Cell Rep. 2019 Sep 24;28(13):3462-3473.e5. do 10.1016/j.celrep.2019.08.058.
Aldr-Kk P, Heuer A, Wang G, Mattsson B, Lundblad M, Parmar M, Bjorklund T. DREADD Modulatn of Transplanted DA Neurons Reveals a Novel Parksonn Dyskes Mechanm Medted by the Seroton 5-HT6 Receptor. Neuron. 2016 Jun 1;90(5):955-68. do 10.1016/j.neuron.2016.04.017. Epub 2016 May 5.
Barker RA, Barrett J, Mason SL, Bjorklund A. Fetal dopamerg transplantatn trls and the future of neural graftg Parkson's dease. Lancet Neurol. 2013 Jan;12(1):84-91. do 10.1016/S1474-4422(12)70295-8.
Barker RA; TRANSEURO consortm. Desng stem-cell-based dopame cell replacement trls for Parkson's dease. Nat Med. 2019 Jul;25(7):1045-1053. do 10.1038/s41591-019-0507-2. Epub 2019 Jul 1.
Barker RA, Foltyn T. The future challenges Parkson's dease. J Neurol. 2004 Mar;251(3):361-5. do 10.1007/s00415-004-0320-8. No abstract avaable.
Barker RA, Parmar M, Studer L, TakahashJ. Human Trls of Stem Cell-Dered Dopame Neurons for Parkson's Dease: Dawn of a New Era. Cell Stem Cell. 2017 Nov 2;21(5):569-573. do 10.1016/j.stem.2017.09.014.
Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del TredK. Stanley Fahn Lecture 2005: The stagg procedure for the clusn body pathology assocted wh sporad Parkson's dease reconsered. Mov Dord. 2006 Dec;21(12):2042-51. do 10.1002/mds.21065.
Braak H, Ghebremedh E, Rub U, Bratzke H, Del TredK. Stages the development of Parkson's dease-related pathology. Cell Tsue Res. 2004 Oct;318(1):121-34. do 10.1007/s00441-004-0956-9. Epub 2004 Aug 24.
Brund P, Pogarell O, Hagell P, PcP, Wner H, Schrag A, Kupsch A, Crabb L, Od P, Gustav B, Bjorklund A, Brooks DJ, Marsden CD, Oertel WH, Qun NP, Rehncrona S, Ldvall O. Bateral caudate and putamen grafts of embryon mesencephal tsue treated wh lazaros Parkson's dease. Bra. 2000 Jul;123 ( Pt 7):1380-90. do 10.1093/bra/123.7.1380.
Cardoso T, Adler AF, Mattsson B, Hoban DB, Nolbrant S, Wahlestedt JN, Kkeby A, Grealh S, Bjorklund A, Parmar M. Target-spec forebra projectns and approprte synapt puts of hESC-dered dopame neurons grafted to the mbra of parksonn rats. J Comp Neurol. 2018 Sep 1;526(13):2133-2146. do 10.1002/cne.24500. Epub 2018 Jul 31.
Defer GL, Geny C, RolfF, Fenelon G, Monfort JC, Remy P, Vlafane G, Jeny R, Samson Y, Keravel Y, Gaston A, Degos JD, PeschanskM, Cesaro P, Nguyen JP. Long-term outcome of unaterally transplanted parksonn patnts. Clal approach. Bra. 1996 Feb;119 ( Pt 1):41-50. do 10.1093/bra/119.1.41.
Evans JR, Barker RA. Neurotroph factors as a therapeut target for Parkson's dease. Expert Op Ther Targets. 2008 Apr;12(4):437-47. do 10.1517/14728222.12.4.437.
Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Krk E, QJX, Lone T, Zhang YB, Snyder JA, Wells TH, et al. Surval of planted fetal dopame cells and neurolog provement 12 to 46 months after transplantatn for Parkson's dease. N Engl J Med. 1992 Nov 26;327(22):1549-55. do 10.1056/NEJM199211263272202.
Freed CR, Greene PE, Breeze RE, TsaWY, DuMouchel W, Kao R, Dlon S, Wfld H, Culver S, TrojanowskJQ, Eelberg D, Fahn S. Transplantatn of embryon dopame neurons for severe Parkson's dease. N Engl J Med. 2001 Mar 8;344(10):710-9. do 10.1056/NEJM200103083441002.
Grealh S, Heuer A, Cardoso T, Kkeby A, Jonsson M, Johansson J, Bjorklund A, Jakobsson J, Parmar M. Monosynapt Tracg usg Modd Rabs Vus Reveals Early and Extense Ccu tegratn of Human Embryon Stem Cell-Dered Neurons. Stem Cell Reports. 2015 Jun 9;4(6):975-83. do 10.1016/j.stemcr.2015.04.011. Epub 2015 May 21.
Hagell P, PcP, Bjorklund A, Brund P, Rehncrona S, Wner H, Crabb L, Pavese N, Oertel WH, Qun N, Brooks DJ, Ldvall O. Dyskess followg neural transplantatn Parkson's dease. Nat Neurosc 2002 Jul;5(7):627-8. do 10.1038/nn863.
Hagell P, Schrag A, PcP, JahanshahM, Brown R, Rehncrona S, Wner H, Brund P, Rothwell JC, Od P, Wenng GK, Morrh P, Gustav B, Bjorklund A, Brooks DJ, Marsden CD, Qun NP, Ldvall O. Sequentl bateral transplantatn Parkson's dease: effects of the second graft. Bra. 1999 Jun;122 ( Pt 6):1121-32. do 10.1093/bra/122.6.1121.
Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW. Long-term evaluatn of bateral fetal nral transplantatn Parkson dease. Arch Neurol. 1999 Feb;56(2):179-87. do 10.1001/archneur.56.2.179.
Heuer A, Kkeby A, Pfterer U, Jonsson ME, Parmar M. hESC-dered neural progenors prevent xenograft rejectn through neonatal desensatn. Exp Neurol. 2016 Aug;282:78-85. do 10.1016/j.expneurol.2016.05.027. Epub 2016 May 25.
Hoban DB, Shrley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Bjorklund A, Parmar M. pact of alpha-synucle pathology on transplanted hESC-dered dopamerg neurons a humaned alpha-synucle rat model of PD. Proc Natl Acad ScU S A. 2020 Jun 30;117(26):15209-15220. do 10.1073/pnas.2001305117. Epub 2020 Jun 15.
Kefalopoulou Z, Pol M, PcP, MencaccN, Bhat K, JahanshahM, Wner H, Rehncrona S, Brund P, Bjorklund A, Ldvall O, Lous P, Qun N, Foltyn T. Long-term clal outcome of fetal cell transplantatn for Parkson dease: two case reports. JAMA Neurol. 2014 Jan;71(1):83-7. do 10.1001/jamaneurol.2013.4749.
Kkeby A, Grealh S, Wolf DA, Nelander J, Wood J, Lundblad M, Ldvall O, Parmar M. Generatn of regnally specd neural progenors and functnal neurons from human embryon stem cells under defed condns. Cell Rep. 2012 Jun 28;1(6):703-14. do 10.1016/j.celrep.2012.04.009. Epub 2012 May 26.
Kkeby A, Nolbrant S, Tlova K, Heuer A, Kee N, Cardoso T, Ottosson DR, Lelos MJ, Res P, Dunnett SB, Grealh S, Perlmann T, Parmar M. Predte Markers Gue Dferenttn to prove Graft Outcome Clal Translatn of hESC-Based Therapy for Parkson's Dease. Cell Stem Cell. 2017 Jan 5;20(1):135-148. do 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.
Krs S, Sh JW, Po J, Ganat YM, Wakeman DR, X Z, Carrlo-Re L, Auyeung G, AntonaccC, Buch A, Yang L, Beal MF, Surmer DJ, Kordower JH, Tabar V, Studer L. Dopame neurons dered from human ES cells effntly engraft anal models of Parkson's dease. Nature. 2011 Nov 6;480(7378):547-51. do 10.1038/nature10648.
Lang AE, Lozano AM. Parkson's dease. Fst of two parts. N Engl J Med. 1998 Oct 8;339(15):1044-53. do 10.1056/NEJM199810083391506. No abstract avaable.
Lang AE, Lozano AM. Parkson's dease. Second of two parts. N Engl J Med. 1998 Oct 15;339(16):1130-43. do 10.1056/NEJM199810153391607.
Lehnen D, Barral S, Cardoso T, Grealh S, Heuer A, Smak A, Kkeby A, Kollet J, Cremer H, Parmar M, Bos A, Knobel S. P-Based Cell Sortg Results Homogeneous Transplantable Dopamerg Precursor Cells Dered from Human Plurotent Stem Cells. Stem Cell Reports. 2017 Oct 10;9(4):1207-1220. do 10.1016/j.stemcr.2017.08.016. Epub 2017 Sep 21.
Lew SJ, Caldwell MA, Barker RA. Modern therapeut approaches Parkson's dease. Expert Rev Mol Med. 2003 Mar 28;5(10):1-20. do 10.1017/S1462399403006008.
LJY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Qun NP, Rehncrona S, Bjorklund A, Wner H, Revesz T, Ldvall O, Brund P. Lewy bods grafted neurons subjects wh Parkson's dease suggest host-to-graft dease propagatn. Nat Med. 2008 May;14(5):501-3. do 10.1038/nm1746. Epub 2008 Apr 6.
LJY, Englund E, Wner H, Rehncrona S, Bjorklund A, Ldvall O, Brund P. Characteratn of Lewy body pathology 12- and 16-year-old trastrtal mesencephal grafts survg a patnt wh Parkson's dease. Mov Dord. 2010 Jun 15;25(8):1091-6. do 10.1002/mds.23012.
LW, Englund E, Wner H, Mattsson B, van Westen D, Latt J, Rehncrona S, Brund P, Bjorklund A, Ldvall O, LJY. Extense graft-dered dopamerg nervatn mataed 24 years after transplantatn the degeneratg parksonn bra. Proc Natl Acad ScU S A. 2016 Jun 7;113(23):6544-9. do 10.1073/pnas.1605245113. Epub 2016 May 2.
Ldvall O, Rehncrona S, Brund P, Gustav B, Astedt B, Wner H, Ldholm T, Bjorklund A, Leenders KL, Rothwell JC, Frackowk R, Marsden D, Johnels B, Steg G, Freedman R, Hoffer BJ, Seer A, Bygdeman M, Stromberg Olson L. Human fetal dopame neurons grafted to the strtum two patnts wh severe Parkson's dease. A detaed account of methodology and a 6-month follow-up. Arch Neurol. 1989 Jun;46(6):615-31. do 10.1001/archneur.1989.00520420033021.
Mendez Dagher A, Hong M, Gaudet P, Weerasghe S, McAlter V, Kg D, Desrosrs J, Darvesh S, Acorn T, Robertson H. Sultaneous trastrtal and tranral fetal dopamerg grafts patnts wh Parkson dease: a pot study. Report of three cases. J Neurosurg. 2002 Mar;96(3):589-96. do 10.3171/jns.2002.96.3.0589.
Nolbrant S, Heuer A, Parmar M, Kkeby A. Generatn of hh-pury human ventral mbra dopamerg progenors for vro maturatn and tracerebral transplantatn. Nat Protoc. 2017 Sep;12(9):1962-1979. do 10.1038/nprot.2017.078. Epub 2017 Aug 31.
Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, SossV, Br MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-bld controlled trl of bateral fetal nral transplantatn Parkson's dease. Ann Neurol. 2003 Sep;54(3):403-14. do 10.1002/ana.10720.
PalfS, Gurruchaga JM, Ralph GS, Lepet H, Lavse S, Buttery PC, Watts C, Mk J, Kelleher M, Deeley S, amuro H, Lefaucheur JP, Thz C, Fenelon G, Lucas C, Brugres P, Gabrl Abhay K, Drouot X, TanN, Kas A, Ghaleh B, Le Corvor P, Dolph P, Breen DP, Mason S, Guzman NV, Mazarak ND, Radclfe PA, Harrop R, Kgsman SM, Rascol O, Naylor S, Barker RA, Hantraye P, Remy P, Cesaro P, Mrophanous KA. Long-term safety and toleraby of ProSav, a lental vector-based gene therapy for Parkson's dease: a dose escalatn, open-label, phase 1/2 trl. Lancet. 2014 Mar 29;383(9923):1138-46. do 10.1016/S0140-6736(13)61939-X. Epub 2014 Jan 10.
Schade S, Mollenhauer B, Trenkwalder C. Levodopa Equalent Dose Conversn Factors: An Updated Proposal cludg Opapone and Safame. Mov Dord Cl Pract. 2020 Mar 16;7(3):343-345. do 10.1002/mdc3.12921. eCollectn 2020 Apr. No abstract avaable.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Tmermann L, Halb TD, Hesekamp H, Navarro SM, Mer N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fk GR, Kupsch A, Gruber D, Schneer GH, Seneuret E, Ktner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnzler A, WojteckL, Houeto JL, Batale B, Maltete D, Damr P, Raoul S, Sel-Doerg F, Hellw D, GharabaghA, Kruger R, Psker MO, Amtage F, Reg JM, Wjas T, Thobo S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Ag Y, Schade-Brtger C, Deuschl G; EARLYST Study Group. Neurostulatn for Parkson's dease wh early motor complatns. N Engl J Med. 2013 Feb 14;368(7):610-22. do 10.1056/NEJMoa1205158.
Schupbach WM, Maltete D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Garglo M, Behar C, Bonnet AM, CzerneckV, Poux B, Navarro S, Dormont D, Cornu P, Ag Y. Neurosurgery at an earlr stage of Parkson dease: a randomed, controlled trl. Neurology. 2007 Jan 23;68(4):267-71. do 10.1212/01.wnl.0000250253.03919.fb. Epub 2006 Dec 6.
Tlova K, Nolbrant S, Frenzano A, Bjorklund AK, Sharma Y, Heuer A, Glberg L, Hoban DB, Cardoso T, Adler AF, Btele M, Lunden-Muel H, Volakak N, Kkeby A, Perlmann T, Parmar M. Sgle cell transcrtoms ents stem cell-dered graft composn a model of Parkson's dease. Nat Commun. 2020 May 15;11(1):2434. do 10.1038/s41467-020-16225-5. Erratum : Nat Commun. 2020 Jul 15;11(1):3630.
Voon V, Krack P, Lang AE, Lozano AM, Dujard K, Schupbach M, D'Ambros J, Thobo S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossnol H, Poon YY, Sat-Cyr JA, Ardou C, Moro E. A multentre study on sue outcomes followg subthalam stulatn for Parkson's dease. Bra. 2008 Oct;131(Pt 10):2720-8. do 10.1093/bra/awn214.
Wer C, Pollo C, Bloch J, Burkhard PR, Vgerhoets FJ. Long-term outcome of 50 consecute Parkson's dease patnts treated wh subthalam deep bra stulatn. Parksonm Relat Dord. 2008;14(2):114-9. do 10.1016/j.parkreld.2007.06.012. Epub 2007 Sep 5.
Weyekoon R, Barker RA. Cell replacement therapy for Parkson's dease. Bch Bphys Acta. 2009 Jul;1792(7):688-702. do 10.1016/j.bbad.2008.10.007. Epub 2008 Oct 25.
Wt K, Danls C, Ref J, Krack P, Volkmann J, Psker MO, Krause M, Tronnr V, Kloss M, Schnzler A, WojteckL, Botzel K, Danek A, Hker R, Sturm V, Kupsch A, Karner E, Deuschl G. Neuropsychologal and psychtr changes after deep bra stulatn for Parkson's dease: a randomed, multentre study. Lancet Neurol. 2008 Jul;7(7):605-14. do 10.1016/S1474-4422(08)70114-5. Epub 2008 Jun 4.
Lansg AE, n RJ, Cullum CM, Randolph C. An empally dered short form of the Boston namg test. Arch Cl Neuropsychol. 1999 Aug;14(6):481-7.
STEM-PD Trial: A Multicentre, Single Arm, First in Human, Dose-escalation Trial, Investigating the Safety and Tolerability of Intraputamenal Transplantation of Human Embryonic Stem Cell Derived Dopaminergic Cells for Parkinson's Disease (STEM-PD Product)
Aldr-Kk P, Heuer A, Wang G, Mattsson B, Lundblad M, Parmar M, Bjorklund T. DREADD Modulatn of Transplanted DA Neurons Reveals a Novel Parksonn Dyskes Mechanm Medted by the Seroton 5-HT6 Receptor. Neuron. 2016 Jun 1;90(5):955-68. do 10.1016/j.neuron.2016.04.017. Epub 2016 May 5.
Barker RA, Barrett J, Mason SL, Bjorklund A. Fetal dopamerg transplantatn trls and the future of neural graftg Parkson's dease. Lancet Neurol. 2013 Jan;12(1):84-91. do 10.1016/S1474-4422(12)70295-8.
Barker RA; TRANSEURO consortm. Desng stem-cell-based dopame cell replacement trls for Parkson's dease. Nat Med. 2019 Jul;25(7):1045-1053. do 10.1038/s41591-019-0507-2. Epub 2019 Jul 1.
Barker RA, Foltyn T. The future challenges Parkson's dease. J Neurol. 2004 Mar;251(3):361-5. do 10.1007/s00415-004-0320-8. No abstract avaable.
Barker RA, Parmar M, Studer L, TakahashJ. Human Trls of Stem Cell-Dered Dopame Neurons for Parkson's Dease: Dawn of a New Era. Cell Stem Cell. 2017 Nov 2;21(5):569-573. do 10.1016/j.stem.2017.09.014.
Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del TredK. Stanley Fahn Lecture 2005: The stagg procedure for the clusn body pathology assocted wh sporad Parkson's dease reconsered. Mov Dord. 2006 Dec;21(12):2042-51. do 10.1002/mds.21065.
Braak H, Ghebremedh E, Rub U, Bratzke H, Del TredK. Stages the development of Parkson's dease-related pathology. Cell Tsue Res. 2004 Oct;318(1):121-34. do 10.1007/s00441-004-0956-9. Epub 2004 Aug 24.
Brund P, Pogarell O, Hagell P, PcP, Wner H, Schrag A, Kupsch A, Crabb L, Od P, Gustav B, Bjorklund A, Brooks DJ, Marsden CD, Oertel WH, Qun NP, Rehncrona S, Ldvall O. Bateral caudate and putamen grafts of embryon mesencephal tsue treated wh lazaros Parkson's dease. Bra. 2000 Jul;123 ( Pt 7):1380-90. do 10.1093/bra/123.7.1380.
Cardoso T, Adler AF, Mattsson B, Hoban DB, Nolbrant S, Wahlestedt JN, Kkeby A, Grealh S, Bjorklund A, Parmar M. Target-spec forebra projectns and approprte synapt puts of hESC-dered dopame neurons grafted to the mbra of parksonn rats. J Comp Neurol. 2018 Sep 1;526(13):2133-2146. do 10.1002/cne.24500. Epub 2018 Jul 31.
Defer GL, Geny C, RolfF, Fenelon G, Monfort JC, Remy P, Vlafane G, Jeny R, Samson Y, Keravel Y, Gaston A, Degos JD, PeschanskM, Cesaro P, Nguyen JP. Long-term outcome of unaterally transplanted parksonn patnts. Clal approach. Bra. 1996 Feb;119 ( Pt 1):41-50. do 10.1093/bra/119.1.41.
Evans JR, Barker RA. Neurotroph factors as a therapeut target for Parkson's dease. Expert Op Ther Targets. 2008 Apr;12(4):437-47. do 10.1517/14728222.12.4.437.
Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Krk E, QJX, Lone T, Zhang YB, Snyder JA, Wells TH, et al. Surval of planted fetal dopame cells and neurolog provement 12 to 46 months after transplantatn for Parkson's dease. N Engl J Med. 1992 Nov 26;327(22):1549-55. do 10.1056/NEJM199211263272202.
Freed CR, Greene PE, Breeze RE, TsaWY, DuMouchel W, Kao R, Dlon S, Wfld H, Culver S, TrojanowskJQ, Eelberg D, Fahn S. Transplantatn of embryon dopame neurons for severe Parkson's dease. N Engl J Med. 2001 Mar 8;344(10):710-9. do 10.1056/NEJM200103083441002.
Grealh S, Heuer A, Cardoso T, Kkeby A, Jonsson M, Johansson J, Bjorklund A, Jakobsson J, Parmar M. Monosynapt Tracg usg Modd Rabs Vus Reveals Early and Extense Ccu tegratn of Human Embryon Stem Cell-Dered Neurons. Stem Cell Reports. 2015 Jun 9;4(6):975-83. do 10.1016/j.stemcr.2015.04.011. Epub 2015 May 21.
Hagell P, PcP, Bjorklund A, Brund P, Rehncrona S, Wner H, Crabb L, Pavese N, Oertel WH, Qun N, Brooks DJ, Ldvall O. Dyskess followg neural transplantatn Parkson's dease. Nat Neurosc 2002 Jul;5(7):627-8. do 10.1038/nn863.
Hagell P, Schrag A, PcP, JahanshahM, Brown R, Rehncrona S, Wner H, Brund P, Rothwell JC, Od P, Wenng GK, Morrh P, Gustav B, Bjorklund A, Brooks DJ, Marsden CD, Qun NP, Ldvall O. Sequentl bateral transplantatn Parkson's dease: effects of the second graft. Bra. 1999 Jun;122 ( Pt 6):1121-32. do 10.1093/bra/122.6.1121.
Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW. Long-term evaluatn of bateral fetal nral transplantatn Parkson dease. Arch Neurol. 1999 Feb;56(2):179-87. do 10.1001/archneur.56.2.179.
Heuer A, Kkeby A, Pfterer U, Jonsson ME, Parmar M. hESC-dered neural progenors prevent xenograft rejectn through neonatal desensatn. Exp Neurol. 2016 Aug;282:78-85. do 10.1016/j.expneurol.2016.05.027. Epub 2016 May 25.
Hoban DB, Shrley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Bjorklund A, Parmar M. pact of alpha-synucle pathology on transplanted hESC-dered dopamerg neurons a humaned alpha-synucle rat model of PD. Proc Natl Acad ScU S A. 2020 Jun 30;117(26):15209-15220. do 10.1073/pnas.2001305117. Epub 2020 Jun 15.
Kefalopoulou Z, Pol M, PcP, MencaccN, Bhat K, JahanshahM, Wner H, Rehncrona S, Brund P, Bjorklund A, Ldvall O, Lous P, Qun N, Foltyn T. Long-term clal outcome of fetal cell transplantatn for Parkson dease: two case reports. JAMA Neurol. 2014 Jan;71(1):83-7. do 10.1001/jamaneurol.2013.4749.
Kkeby A, Grealh S, Wolf DA, Nelander J, Wood J, Lundblad M, Ldvall O, Parmar M. Generatn of regnally specd neural progenors and functnal neurons from human embryon stem cells under defed condns. Cell Rep. 2012 Jun 28;1(6):703-14. do 10.1016/j.celrep.2012.04.009. Epub 2012 May 26.
Kkeby A, Nolbrant S, Tlova K, Heuer A, Kee N, Cardoso T, Ottosson DR, Lelos MJ, Res P, Dunnett SB, Grealh S, Perlmann T, Parmar M. Predte Markers Gue Dferenttn to prove Graft Outcome Clal Translatn of hESC-Based Therapy for Parkson's Dease. Cell Stem Cell. 2017 Jan 5;20(1):135-148. do 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.
Krs S, Sh JW, Po J, Ganat YM, Wakeman DR, X Z, Carrlo-Re L, Auyeung G, AntonaccC, Buch A, Yang L, Beal MF, Surmer DJ, Kordower JH, Tabar V, Studer L. Dopame neurons dered from human ES cells effntly engraft anal models of Parkson's dease. Nature. 2011 Nov 6;480(7378):547-51. do 10.1038/nature10648.
Lang AE, Lozano AM. Parkson's dease. Fst of two parts. N Engl J Med. 1998 Oct 8;339(15):1044-53. do 10.1056/NEJM199810083391506. No abstract avaable.
Lang AE, Lozano AM. Parkson's dease. Second of two parts. N Engl J Med. 1998 Oct 15;339(16):1130-43. do 10.1056/NEJM199810153391607.
Lehnen D, Barral S, Cardoso T, Grealh S, Heuer A, Smak A, Kkeby A, Kollet J, Cremer H, Parmar M, Bos A, Knobel S. P-Based Cell Sortg Results Homogeneous Transplantable Dopamerg Precursor Cells Dered from Human Plurotent Stem Cells. Stem Cell Reports. 2017 Oct 10;9(4):1207-1220. do 10.1016/j.stemcr.2017.08.016. Epub 2017 Sep 21.
Lew SJ, Caldwell MA, Barker RA. Modern therapeut approaches Parkson's dease. Expert Rev Mol Med. 2003 Mar 28;5(10):1-20. do 10.1017/S1462399403006008.
LJY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Qun NP, Rehncrona S, Bjorklund A, Wner H, Revesz T, Ldvall O, Brund P. Lewy bods grafted neurons subjects wh Parkson's dease suggest host-to-graft dease propagatn. Nat Med. 2008 May;14(5):501-3. do 10.1038/nm1746. Epub 2008 Apr 6.
LJY, Englund E, Wner H, Rehncrona S, Bjorklund A, Ldvall O, Brund P. Characteratn of Lewy body pathology 12- and 16-year-old trastrtal mesencephal grafts survg a patnt wh Parkson's dease. Mov Dord. 2010 Jun 15;25(8):1091-6. do 10.1002/mds.23012.
LW, Englund E, Wner H, Mattsson B, van Westen D, Latt J, Rehncrona S, Brund P, Bjorklund A, Ldvall O, LJY. Extense graft-dered dopamerg nervatn mataed 24 years after transplantatn the degeneratg parksonn bra. Proc Natl Acad ScU S A. 2016 Jun 7;113(23):6544-9. do 10.1073/pnas.1605245113. Epub 2016 May 2.
Ldvall O, Rehncrona S, Brund P, Gustav B, Astedt B, Wner H, Ldholm T, Bjorklund A, Leenders KL, Rothwell JC, Frackowk R, Marsden D, Johnels B, Steg G, Freedman R, Hoffer BJ, Seer A, Bygdeman M, Stromberg Olson L. Human fetal dopame neurons grafted to the strtum two patnts wh severe Parkson's dease. A detaed account of methodology and a 6-month follow-up. Arch Neurol. 1989 Jun;46(6):615-31. do 10.1001/archneur.1989.00520420033021.
Mendez Dagher A, Hong M, Gaudet P, Weerasghe S, McAlter V, Kg D, Desrosrs J, Darvesh S, Acorn T, Robertson H. Sultaneous trastrtal and tranral fetal dopamerg grafts patnts wh Parkson dease: a pot study. Report of three cases. J Neurosurg. 2002 Mar;96(3):589-96. do 10.3171/jns.2002.96.3.0589.
Nolbrant S, Heuer A, Parmar M, Kkeby A. Generatn of hh-pury human ventral mbra dopamerg progenors for vro maturatn and tracerebral transplantatn. Nat Protoc. 2017 Sep;12(9):1962-1979. do 10.1038/nprot.2017.078. Epub 2017 Aug 31.
Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, SossV, Br MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-bld controlled trl of bateral fetal nral transplantatn Parkson's dease. Ann Neurol. 2003 Sep;54(3):403-14. do 10.1002/ana.10720.
PalfS, Gurruchaga JM, Ralph GS, Lepet H, Lavse S, Buttery PC, Watts C, Mk J, Kelleher M, Deeley S, amuro H, Lefaucheur JP, Thz C, Fenelon G, Lucas C, Brugres P, Gabrl Abhay K, Drouot X, TanN, Kas A, Ghaleh B, Le Corvor P, Dolph P, Breen DP, Mason S, Guzman NV, Mazarak ND, Radclfe PA, Harrop R, Kgsman SM, Rascol O, Naylor S, Barker RA, Hantraye P, Remy P, Cesaro P, Mrophanous KA. Long-term safety and toleraby of ProSav, a lental vector-based gene therapy for Parkson's dease: a dose escalatn, open-label, phase 1/2 trl. Lancet. 2014 Mar 29;383(9923):1138-46. do 10.1016/S0140-6736(13)61939-X. Epub 2014 Jan 10.
Schade S, Mollenhauer B, Trenkwalder C. Levodopa Equalent Dose Conversn Factors: An Updated Proposal cludg Opapone and Safame. Mov Dord Cl Pract. 2020 Mar 16;7(3):343-345. do 10.1002/mdc3.12921. eCollectn 2020 Apr. No abstract avaable.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Tmermann L, Halb TD, Hesekamp H, Navarro SM, Mer N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fk GR, Kupsch A, Gruber D, Schneer GH, Seneuret E, Ktner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnzler A, WojteckL, Houeto JL, Batale B, Maltete D, Damr P, Raoul S, Sel-Doerg F, Hellw D, GharabaghA, Kruger R, Psker MO, Amtage F, Reg JM, Wjas T, Thobo S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Ag Y, Schade-Brtger C, Deuschl G; EARLYST Study Group. Neurostulatn for Parkson's dease wh early motor complatns. N Engl J Med. 2013 Feb 14;368(7):610-22. do 10.1056/NEJMoa1205158.
Schupbach WM, Maltete D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Garglo M, Behar C, Bonnet AM, CzerneckV, Poux B, Navarro S, Dormont D, Cornu P, Ag Y. Neurosurgery at an earlr stage of Parkson dease: a randomed, controlled trl. Neurology. 2007 Jan 23;68(4):267-71. do 10.1212/01.wnl.0000250253.03919.fb. Epub 2006 Dec 6.
Tlova K, Nolbrant S, Frenzano A, Bjorklund AK, Sharma Y, Heuer A, Glberg L, Hoban DB, Cardoso T, Adler AF, Btele M, Lunden-Muel H, Volakak N, Kkeby A, Perlmann T, Parmar M. Sgle cell transcrtoms ents stem cell-dered graft composn a model of Parkson's dease. Nat Commun. 2020 May 15;11(1):2434. do 10.1038/s41467-020-16225-5. Erratum : Nat Commun. 2020 Jul 15;11(1):3630.
Voon V, Krack P, Lang AE, Lozano AM, Dujard K, Schupbach M, D'Ambros J, Thobo S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossnol H, Poon YY, Sat-Cyr JA, Ardou C, Moro E. A multentre study on sue outcomes followg subthalam stulatn for Parkson's dease. Bra. 2008 Oct;131(Pt 10):2720-8. do 10.1093/bra/awn214.
Wer C, Pollo C, Bloch J, Burkhard PR, Vgerhoets FJ. Long-term outcome of 50 consecute Parkson's dease patnts treated wh subthalam deep bra stulatn. Parksonm Relat Dord. 2008;14(2):114-9. do 10.1016/j.parkreld.2007.06.012. Epub 2007 Sep 5.
Weyekoon R, Barker RA. Cell replacement therapy for Parkson's dease. Bch Bphys Acta. 2009 Jul;1792(7):688-702. do 10.1016/j.bbad.2008.10.007. Epub 2008 Oct 25.
Wt K, Danls C, Ref J, Krack P, Volkmann J, Psker MO, Krause M, Tronnr V, Kloss M, Schnzler A, WojteckL, Botzel K, Danek A, Hker R, Sturm V, Kupsch A, Karner E, Deuschl G. Neuropsychologal and psychtr changes after deep bra stulatn for Parkson's dease: a randomed, multentre study. Lancet Neurol. 2008 Jul;7(7):605-14. do 10.1016/S1474-4422(08)70114-5. Epub 2008 Jun 4.
Lansg AE, n RJ, Cullum CM, Randolph C. An empally dered short form of the Boston namg test. Arch Cl Neuropsychol. 1999 Aug;14(6):481-7.
STEM-PD Trial: A Multicentre, Single Arm, First in Human, Dose-escalation Trial, Investigating the Safety and Tolerability of Intraputamenal Transplantation of Human Embryonic Stem Cell Derived Dopaminergic Cells for Parkinson's Disease (STEM-PD Product)
Report
University of Auckland, New Zealand; University of Aarhus; Cambridge University Hospitals NHS Foundation Trust
A Qualitative Research Study Using Patient Focus Groups to Translate International Consensus Definition of Low Anterior Resection Syndrome (LARS) Into a Bowel Dysfunction Severity Scoring Tool.
Report
Conroy P, Sotopoulou Drosopoulou C, Humphreys GF, HalaAD, Lambon Ralph MA. Te for a quk word? The strg benefs of trag speed and accuracy of word retrval post-stroke aphas. Bra. 2018 Jun 1;141(6):1815-1827. do 10.1093/bra/awy087.
Testing the Effect of Speeded Anomia Therapy in Patients With Chronic Post-stroke Aphasia: a Cross-over Randomized Controlled Trial
Testing the Effect of Speeded Anomia Therapy in Patients With Chronic Post-stroke Aphasia: a Cross-over Randomized Controlled Trial
Report
Optical PD-L1 Imaging Using Quantitative Fluorescence Endoscopy in Locally Advanced Esophageal Cancer Using Durvalumab-680LT: a Multicenter Feasibility and Safety Study
검색 결과 제한하기
제한된 항목
[AR] Cambridge University Hospitals NHS Foundation Trust
발행연도 제한
-
학술DB(Database Provider)
출판사(Publisher)
자료유형(Source Type)
주제어
언어